Unrelated alternative donor transplantation for severe acquired aplastic
- Slides: 5
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party by Raynier Devillier, Jean-Hugues Dalle, Austin Kulasekararaj, Maud D’aveni, Laurence Clément, Alicja Chybicka, Stéphane Vigouroux, Patrice Chevallier, Mickey Koh, Yves Bertrand, Mauricette Michallet, Marco Zecca, Ibrahim Yakoub-Agha, Jean -Yves Cahn, Per Ljungman, Marc Bernard, Pascale Loiseau, Valérie Dubois, Sébastien Maury, Gérard Socié, Carlo Dufour, and Regis Peffault de Latour haematol Volume 101(7): 884 -890 June 30, 2016 © 2016 by Ferrata Storti Foundation
Patients’, disease and transplantation characteristics in the study population. Raynier Devillier et al. Haematologica 2016; 101: 884 -890 © 2016 by Ferrata Storti Foundation
Cumulative incidences of acute and chronic graft-versus-host disease in the study population. Raynier Devillier et al. Haematologica 2016; 101: 884 -890 © 2016 by Ferrata Storti Foundation
Univariate and multivariate analyses of overall survival in the study population. Raynier Devillier et al. Haematologica 2016; 101: 884 -890 © 2016 by Ferrata Storti Foundation
Overall survival by the presence of selected risk factors: age > 30 years; time from diagnosis to allogeneic hematopoietic stem cell transplantation (allo-HSCT) > 12 months; presence of an HLA mismatch. Raynier Devillier et al. Haematologica 2016; 101: 884 -890 © 2016 by Ferrata Storti Foundation
